Please check your internet connection and try again.
# Hepamerz (l-Ornithine l-Aspartate)
## Overview
Hepamerz is a combination of the amino acids l-ornithine and l-aspartate. It is used in the management of hyperammonemia associated with liver insufficiency.
## Primary Indications
* Treatment of latent and manifest hepatic encephalopathy.
* Supportive treatment for liver disease.
## Adult Dosing
* **Hepatic Encephalopathy:** Commonly administered intravenously at doses ranging from 10 grams to 30 grams per day, often divided into 2-3 infusions. Typical initial dose is 5 grams infused over 30 minutes. Higher doses may be used in severe cases. Oral formulations are also available, typically 3-6 grams three times daily.
* **Dose depends on severity of hepatic encephalopathy and patient tolerance.** Specific protocols vary by institution.
## Pediatric Dosing
* Data on pediatric use is limited, and dosing should be determined by a specialist.
## Dose Adjustments
* No specific dose adjustments are generally recommended for renal or hepatic impairment, as the drug is primarily metabolized by the liver and excreted by the kidneys after being incorporated into metabolic pathways. However, caution is advised in severe renal impairment due to potential accumulation.
## Contraindications
* Severe hypersensitivity to l-ornithine or l-aspartate.
* Use with caution in patients with bradycardia, as ornithine may exacerbate it.
## Adverse Effects
* Nausea, vomiting, abdominal discomfort.
* Rarely: skin rash, headache, dizziness.
* Intravenous administration can cause phlebitis at the injection site.
## Key Drug Interactions
* No significant drug interactions are well-established.
## Monitoring
* Monitor ammonia levels.
* Assess for signs and symptoms of hepatic encephalopathy.
* Observe for adverse effects.
## Clinical Pearls
* Hepamerz works by stimulating the urea cycle, promoting the detoxification of ammonia in the liver, and by enhancing the synthesis of glutamine in peripheral tissues.
* Intravenous administration should be done with caution to avoid extravasation.
* Oral administration should be taken with meals.
***
**Disclaimer:** This information is intended for clinical pharmacists and healthcare professionals. It is essential to consult the most current official prescribing information and institutional protocols before administering any medication. Dosing and recommendations may vary based on individual patient factors and evolving medical knowledge.
